Top

Annals of Nuclear Medicine

Published in:

01-12-2012 | Original article

Efficacy of ^99mTc-sestamibi SPECT/CT for minimally invasive parathyroidectomy: comparative study with ^99mTc-sestamibi scintigraphy, SPECT, US and CT

Authors: Yong-il Kim, Young Ho Jung, Ki Tae Hwang, Ho-Young Lee

Published in: Annals of Nuclear Medicine | Issue 10/2012

Abstract

Purpose

We evaluated the efficacy of ^99mTc-sestamibi SPECT/CT for planning minimally invasive parathyroidectomy (MIP), comparing with dual phase ^99mTc-sestamibi scintigraphy, ^99mTc-sestamibi SPECT and conventional imaging (US and CT).

Methods

Thirty-one patients (M:F = 10:21, range 35–78 years old) who showed high serum parathyroid hormone (intact PTH) level were included. ^99mTc-sestamibi scintigraphy was performed 15 and 150 min after injection of ^99mTc-sestamibi (555 MBq), and ^99mTc-sestamibi SPECT/CT was obtained just after the delayed scan. Comparison study between imaging modalities was done by patient-based and lesion location-based analysis. The location of the lesion was confirmed by the operative finding. An operation was performed in 24 patients. Seven patients had normal ^99mTc-sestamibi SPECT/CT, and followed for more than 6 months after SPECT/CT.

Results

Among 24 patients, parathyroid adenoma was detected in 19 patients and the other 5 had parathyroid hyperplasia (total 35 lesions). ^99mTc-sestamibi scintigraphy detected abnormal uptake in 15 patients with 24 lesions. Conventional imaging identified abnormal findings in 17 patients with 27 lesions. SPECT detected abnormal findings in 18 patients with 27 lesions. SPECT/CT identified abnormal findings in 24 patients with 35 lesions. SPECT/CT demonstrated 100 % sensitivity in a patient-based analysis. SPECT/CT exhibited significantly better sensitivity than ^99mTc-sestamibi scintigraphy, SPECT and conventional imaging (p < 0.05). All lesion location was correctly identified to perform MIP. The final clinical diagnosis of 7 normal SPECT/CT patients was secondary hyperparathyroidism on 6 months follow-up.

Conclusions

We correctly identified the precise location of parathyroid adenomas or hyperplasia by ^99mTc-sestamibi SPECT/CT which was helpful to perform MIP.

Mariani G, Gulec SA, Rubello D, Boni G, Puccini M, Pelizzo MR, et al. Preoperative localization and radioguided parathyroid surgery. J Nucl Med. 2003;44:1443–58.PubMed

Rubello D, Gross MD, Mariani G, AL-N A. Scintigraphic techniques in primary hyperparathyroidism: from pre-operative localisation to intra-operative imaging. Eur J Nucl Med Mol Imaging. 2007;34:926–33.PubMedCrossRef

Hetrakul N, Civelek AC, Stagg CA, Udelsman R. In vitro accumulation of technetium-99m-sestamibi in human parathyroid mitochondria. Surgery. 2001;130:1011–8.PubMedCrossRef

Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg. 2005;132:359–72.PubMedCrossRef

Hopkins CR, Reading CC. Thyroid and parathyroid imaging. Semin Ultrasound CT MR. 1995;16:279–95.PubMedCrossRef

Tziakouri C, Eracleous E, Skannavis S, Pierides A, Symeonides P, Gourtsoyiannis N. Value of ultrasonography, CT and MR imaging in the diagnosis of primary hyperparathyroidism. Acta Radiol. 1996;37:720–6.PubMedCrossRef

Levy JM, Kandil E, Yau LC, Cuda JD, Sheth SN, Tufano RP. Can ultrasound be used as the primary screening modality for the localization of parathyroid disease prior to surgery for primary hyperparathyroidism? A review of 440 cases. ORL J Otorhinolaryngol Relat Spec. 2011;73:116–20.PubMedCrossRef

Lloyd MN, Lees WR, Milroy EJ. Pre-operative localisation in primary hyperparathyroidism. Clin Radiol. 1990;41:239–43.PubMedCrossRef

Ahuja AT, Wong KT, Ching AS, Fung MK, Lau JY, Yuen EH, et al. Imaging for primary hyperparathyroidism—what beginners should know. Clin Radiol. 2004;59:967–76.PubMedCrossRef

10.

Dill T. Contraindications to magnetic resonance imaging. Heart. 2008;94:943–8.PubMedCrossRef

11.

Sukan A, Reyhan M, Aydin M, Yapar AF, Sert Y, Canpolat T, et al. Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging. Ann Nucl Med. 2008;22:123–31.PubMedCrossRef

12.

Krausz Y, Bettman L, Guralnik L, Yosilevsky G, Keidar Z, Bar-Shalom R, et al. Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism. World J Surg. 2006;30:76–83.PubMedCrossRef

13.

Neumann DR, Obuchowski NA, Difilippo FP. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism. J Nucl Med. 2008;49:2012–7.PubMedCrossRef

14.

Serra A, Bolasco P, Satta L, Nicolosi A, Uccheddu A, Piga M. Role of SPECT/CT in the preoperative assessment of hyperparathyroid patients. Radiol Med. 2006;111:999–1008.PubMedCrossRef

15.

Kaplan EL, Yashiro T, Salti G. Primary hyperparathyroidism in the, choice of surgical procedures for this disease. Ann Surg. 1990;1992(215):300–17.

16.

Gupta VK, Yeh KA, Burke GJ, Wei JP. 99m-Technetium sestamibi localized solitary parathyroid adenoma as an indication for limited unilateral surgical exploration. Am J Surg. 1998;176:409–12.PubMedCrossRef

17.

Rubello D, Pelizzo MR, Casara D. Nuclear medicine and minimally invasive surgery of parathyroid adenomas: a fair marriage. Eur J Nucl Med Mol Imaging. 2003;30:189–92.PubMedCrossRef

18.

Sackett WR, Barraclough B, Reeve TS, Delbridge LW. Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg. 2002;137:1055–9.PubMedCrossRef

19.

Carter WB, Carter DL, Cohn HE. Cause and current management of reoperative hyperparathyroidism. Am Surg. 1993;59:120–4.PubMed

20.

Roach PJ, Schembri GP, Ho Shon IA, Bailey EA, Bailey DL. SPECT/CT imaging using a spiral CT scanner for anatomical localization: impact on diagnostic accuracy and reporter confidence in clinical practice. Nucl Med Commun. 2006;27:977–87.PubMedCrossRef

21.

Krausz Y, Israel O. Single-photon emission computed tomography/computed tomography in endocrinology. Semin Nucl Med. 2006;36:267–74.PubMedCrossRef

22.

Buck AK, Nekolla S, Ziegler S, Beer A, Krause BJ, Herrmann K, et al. SPECT/CT. J Nucl Med. 2008;49:1305–19.PubMedCrossRef

23.

Patel CN, Chowdhury FU, Scarsbrook AF. Hybrid SPECT/CT: the end of “unclear” medicine. Postgrad Med J. 2009;85:606–13.PubMedCrossRef

24.

Mariani G, Bruselli L, Kuwert T, Kim EE, Flotats A, Israel O, et al. A review on the clinical uses of SPECT/CT. Eur J Nucl Med Mol Imaging. 2010;37:1959–85.PubMedCrossRef

25.

Bybel B, Brunken RC, DiFilippo FP, Neumann DR, Wu G, Cerqueira MD. SPECT/CT imaging: clinical utility of an emerging technology. Radiographics. 2008;28:1097–113.PubMedCrossRef

26.

Patel CN, Chowdhury FU, Scarsbrook AF. Clinical utility of hybrid SPECT-CT in endocrine neoplasia. AJR Am J Roentgenol. 2008;190:815–24.PubMedCrossRef

27.

Torregrosa JV, Palomar MR, Pons F, Sabater L, Gilabert R, Llovera J, et al. Has double-phase MIBI scintigraphy usefulness in the diagnosis of hyperparathyroidism? Nephrol Dial Transplant. 1998;13(Suppl 3):37–40.PubMedCrossRef

28.

Lorberboym M, Minski I, Macadziob S, Nikolov G, Schachter P. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med. 2003;44:904–8.PubMed

29.

Rubello D, Massaro A, Cittadin S, Rampin L, Al-Nahhas A, Boni G, et al. Role of 99mTc-sestamibi SPECT in accurate selection of primary hyperparathyroid patients for minimally invasive radio-guided surgery. Eur J Nucl Med Mol Imaging. 2006;33:1091–4.PubMedCrossRef

30.

Hindie E, Ugur O, Fuster D, O’Doherty M, Grassetto G, Urena P, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009;36:1201–16.PubMedCrossRef

31.

Gayed IW, Kim EE, Broussard WF, Evans D, Lee J, Broemeling LD, et al. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med. 2005;46:248–52.PubMed

32.

Oksuz MO, Dittmann H, Wicke C, Mussig K, Bares R, Pfannenberg C, et al. Accuracy of parathyroid imaging: a comparison of planar scintigraphy, SPECT, SPECT-CT, and C-11 methionine PET for the detection of parathyroid adenomas and glandular hyperplasia. Diagn Interv Radiol. 2011;17:297–307.PubMed

33.

Gulec S, Uğur O. The intellectual and scientific basis of parathyroid surgery. Turk J Med Sci. 2004;34:81–4.

34.

Harris L, Yoo J, Driedger A, Fung K, Franklin J, Gray D, et al. Accuracy of technetium-99m SPECT-CT hybrid images in predicting the precise intraoperative anatomical location of parathyroid adenomas. Head Neck. 2008;30:509–17.PubMedCrossRef

35.

Lavely WC, Goetze S, Friedman KP, Leal JP, Zhang Z, Garret-Mayer E, et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase 99mTc-sestamibi parathyroid scintigraphy. J Nucl Med. 2007;48:1084–9.PubMedCrossRef

Title: Efficacy of 99mTc-sestamibi SPECT/CT for minimally invasive parathyroidectomy: comparative study with 99mTc-sestamibi scintigraphy, SPECT, US and CT
Authors: Yong-il Kim
Young Ho Jung
Ki Tae Hwang
Ho-Young Lee
Publication date: 01-12-2012
Publisher: Springer Japan
Published in: Annals of Nuclear Medicine / Issue 10/2012
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI: https://doi.org/10.1007/s12149-012-0641-0

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Efficacy of ^99mTc-sestamibi SPECT/CT for minimally invasive parathyroidectomy: comparative study with ^99mTc-sestamibi scintigraphy, SPECT, US and CT

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 10/2012

Tracheal involvement in ulcerative colitis: clinical presentation and potential interest of 2-deoxy-2[18F]fluoro-d-glucose positron emission tomography (18F-FDG PET) for the management

18F-FAMT in patients with multiple myeloma: clinical utility compared to 18F-FDG

A case of pulmonary choriocarcinoma metastasis with unusual FDG-PET and CT findings: correlation with pathology

Regional cerebral blood flow in patients with carbon monoxide intoxication

A comparative study of breast-specific gamma imaging with the conventional imaging modality in breast cancer patients with dense breasts

Discrepancy of left and right hip bone mineral density (BMD) in Thai women: diagnostic agreement and misclassification